Syneos Health has hired Michael Brooks to fill the new role of chief development officer. Brooks, previously president and global head of LabCorp (Covance) clinical development and commercialization services, will oversee the organization’s customer engagement and market development portfolio.
“COVID-19 has forever changed the way we work with customers and colleagues, and how we effectively engage with patients and health care providers. It’s more important than ever that we drive innovation and find new ways to deliver exceptional customer experiences across the product development lifecycle,” said Syneos Health CEO Alistair Macdonald in a statement. “Michael is a top industry talent with a bold vision for how we can use the breadth of our best-in-class capabilities to solve customer problems.”